Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × Liquid Biopsy × Endocrine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 7 Endocrine 1

Conditions

Neuroendocrine Tumors 2 Multiple Endocrine Neoplasia Type 2a 1 Lung Neoplasms 1

Interventions

Paclitaxel 3 selpercatinib 2 atezolizumab 2 Radiosurgery 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 vandetanib 1 taxane 1 sargramostim 1 repotrectinib 1 pralsetinib 1 niraparib 1 liposomal doxorubicin 1 dostarlimab 1 aldesleukin 1 Vinorelbine 1 Topotecan 1 Thalidomide 1 Temozolomide 1 Specimen Handling 1 Rose Bengal 1 Radiotherapy 1 RRx-001 1 Pemetrexed 1 Oxaliplatin 1 Liquid Biopsy 1 Leucovorin 1 Immunoglobulin G 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06081270 2023-10-13

MUT-ONC

University of Milano Bicocca

EndocrineThoracic

Lung Neoplasms, Multiple Endocrine Neoplasia Type 2a

Data powered by HemOnc (CC BY 4.0) Colophon ⚡